CSF2RA gene-corrected pulmonary macrophage transplantation therapy (Cincinnati Children's Hospital Medical Center)

N/A

Report date: 2025/06/11 10:22:38

Base Information

Drug NameCSF2RA gene-corrected pulmonary macrophage transplantation therapy (Cincinnati Children's Hospital Medical Center)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Macrophages therapy
Mechanisms of ActionMacrophages stimulants
TargetsNot applicable
Therapy Area/IndicationsProteostasis Deficiencies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCincinnati Children'S Hospital Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesCincinnati Children'S Hospital Medical Center
Inactive CompaniesN/A
Active IndicationsProteostasis Deficiencies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A